Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Medtronic sent all affected customers an Urgent Medical Device Sale Removal and Correction Letter recommending the return of devices to Medtronic after disposing of the battery assembly.

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the ...

In April, Medtronic obtained FDA approval for another new product, Inceptiv, a spinal cord stimulator for treating chronic pain. The device can automatically adjust the therapy — a unique feature — to ...

A month has gone by since the last earnings report for Medtronic (MDT). Shares have added about 0.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Medtronic stock rallied on the report but is still down more than 30% from its record high set in late 2021. Here's why I believe now is a good time to add shares of Medtronic to your portfolio.

DUBLIN (AP) — DUBLIN (AP) — Medtronic PLC (MDT) on Tuesday reported fiscal first-quarter net income of $1.04 billion. The Dublin-based company said it had net income of 80 cents per share.

Despite leadership changes, with CFO Karen Parkhill set to join HP Inc (NYSE:HPQ). and Gary Corona assuming the interim CFO role, Medtronic has reiterated its financial outlook for the first ...

In a closely watched medical development, Medtronic edged out competitors in securing U.S. Food and Drug Administration approval for a new cardiac device designed to treat a specific type of ...

Shares of Medtronic PLC MDT advanced 1.52% to $89.47 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...

Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...